Faculty Profile: Ivan Miller, PHD

Ivan Miller, PHD
Professor of Psychiatry & Human Behavior
Psychiatry & Human Behavior
Work: +1 401-455-6383
Ivan Miller is interested in the assessment and treatment of mood disorders, including major depression, dysthymia and bipolar disorder. He also has specific interests in the treatment of suicidal patients and in family approaches to mood disorders.

Institutions

Rih

Research Description

Ivan Miller is interested in the assessment and treatment of mood disorders, including major depression, dysthymia and bipolar disorder. He also has specific interests in the treatment of suicidal patients and in family approaches to mood disorders.

Grants and Awards

Fellow, Academy of Cognitive Therapy

Affiliations

American Psychological Association (APA)

Association for Behavioral and Cognitive Therapies (ABCT; formerly known as Association for the Advancement of Behavior Therapy, AABT)

Association for Clinical Psychosocial Research

Society for Psychotherapy Research

Society for Psychopathological Research

American Psychological Society

Academy of Cognitive Therapy

Funded Research

1. Program Director, "Minority High School Research Apprenticeship Program,"
National Institute of Mental Health (NIMH), 1984-1985. $3,000.

2. Program Director, Biomedical Research Support Grant, Butler Hospital,
NIMH, 1984-1985. $13,500; 1985-1986. $24,500.

3. Co-principal investigator, "Attributions and Learned Helplessness in Clinical Depression."
NIMH (RO1), 4/1/79 - 3/30/81. $90,000,

4. Principal investigator (PI), "Psychological Treatment of Depressed Inpatients."
NIMH (RO1). 10/1/81 - 9/30/86. $296,392,

5. Principal Investigator, "Collaborative Study of Family Assessment: A Preliminary Conference."
W. T. Grant Foundation. 1/1/86-6/30/87. $10,000,

6. Investigator, "Family/Child Study of Affective and Anxiety Disorders," A. Sameroff, PI.
NIMH (RO1). 10/1/89 - 9/30/94. $1,188,859,

7. Site Coordinator, "DSM-IV Field Trial on Dysthymia." M.B. Keller, PI.
American Psychiatric Association (APA). 11/1/90-1/1/92. $15,000,

8. Co-Principal Investigator, "Double-blind Comparison of 3 Fixed doses of Tandospirone and Placebo Administered B.I.D. in Outpatients with Major Depression." G.I. Keitner, PI.
Pfizer Pharmaceuticals. 1/1/91-1/1/92. $124,992,

9. Principal Investigator, "Suicide Ideation Scale Validation in Depressed Inpatients."
Eli Lilly and Co. 9/1/91-8/30/92. $200,624,

10. Co-Principal Investigator, "A Phase II, Multicenter, Randomized , Parallel-Group, Double Blind, Dose-Finding study of 3 Different Doses of Roxindole vs. Placebo in Outpatients with Major Depression," M. B. Keller, PI.
EM Industries, 6/93 - 7/94. $93,492.

11. Principal Investigator, "Matched vs. Mismatched Treatment of Depressed Inpatients."
NIMH (RO1). 4/1/90-3/30/96. $1,360,825,

12. Co-Principal Investigator, "Coping with Depression in Smoking Cessation." R.A. Brown PI.
American Cancer Society. 6/1/92-5/31/95. $296,000,

13. Principal Investigator, "Family Treatment of Bipolar Disorder."
NIMH (RO1). 9/1/92 - 2/28/99. $2,196,753,

14. Co-Principal Investigator, "Coping with Depression in Smoking Cessation." R.A. Brown PI.
National Institute on Drug Abuse (NIDA) (RO1). 3/1/93-2/281/98. $1,450,502,

15. Co-Principal Investigator, "Double-blind parallel comparison of sertraline and imipramine in outpatients with concurrent DSM-IIIR Major Depression and Dsythymia," M. Keller, PI.
Pfizer, Incorporated. 4/1/93 - 3/30/97. $600,000,

16. Co-Principal Investigator, "Double-blind parallel comparison of sertraline and imipramine in outpatients with Chronic Major Depression," M. Keller, PI.
Pfizer, Incorporated. 4/1/93 - 3/30/97. $600,000,

17. Investigator, "Fluoxetine vs. Sertraline and Paroxetine in Major Depression: Comparison of Discontinuation/Emergent Signs and Symptoms." G. Keitner, PI.
Lilly, 9/1/96 -9/1/97. $100,000.

18. Investigator, "Multicenter, Placebo-Controlled Study of Relapse Prevention by Long-Term Treatment with Remeron in Outpatients with Major Depressive Episode" M. Keller, PI.
Organon, 9/97- 3/99. $217,000.

19. Principal Investigator, "Family Treatment of Bipolar Disorder" Competitive Services Research Supplement,
NIMH, 9/30/94 - 2/28/99. $579,390.

20. Co-Principal Investigator, "Development of a Family Telephone Contact Intervention for Stroke Patients." Duane S. Bishop, PI.
NIMH (R21). 4/1/95 - 3/31/98. $505,249.

21. Investigator, "Community Treatment of Adolescent Suicide Attempters."
A. Spirito, PI.
NIMH (RO1), 5/1/96-4/30/99. $300,000.

22. Co-Principal Investigator, "An Efficacy Study of Serzone, Psychotherapy, and Their Combination in the Treatment of Chronic Depression," M. Keller, PI.
Bristol Myers Squibb, Inc. $798,000. 6/1/96-5/31/99.

23. Investigator, "Thyroxine Treatment of the Neurocognitive Side Effects of Lithium." R. Stern, PI.
National Alliance for Research on Schizophrenia and Depression (NARSAD), 5/97-4/98. $99,985.

24. Sponsor, "Electrophysiological Predictors of Relapse in Schizophrenia." W. McDermut, PI.
NARSAD, 7/1/97-6/30/99. $60,000.

25. Investigator, "Efficacy of Depression Skills Treatment with Alcoholics." R. Brown, PI.
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (RO1), 4/97- 3/01. $1,297,095.

26. Investigator, "Coping with Depression In Smoking Cessation." R. Brown, PI.
NIDA (RO1), 6/1/97-3/31/01. $1,412,600.

27. Co-Principal Investigator, "Research Training in Combined Treatment Modalities." T. Shea, PI.
NIMH (T32), 6/97-5/02. $1,271,542.

28. Sponsor, "The Role of Family Functioning in the Course and Treatment of Major Depression." Michael Friedman, PI.
NIMH (F32), 7/98-6/99. $26,000.

29. Investigator, "Olanzapine vs. Placebo in the Treatment of Bipolar Disorder." G. Keitner, PI.
Lilly, 2/98 - 6/99. $279,187.

30. Investigator, "Predicting Alliance Difficulties." Benjamin Johnson, PI.
NIMH (RO3), 7/1/98-6/30/99. $38,750.

31. Principal Investigator, "Effectiveness of a Family Telephone Intervention for Stroke Patients."
National Institute of Neurological Disorders and Stroke (NINDS) (RO1), 8/1/98-2/1/06. $2,540,523.

32. Co-Principal Investigator, "An Eight Week, Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled, Study of St. John's Wort in Outpatients with DSM-IV Major Depression," M. Keller, PI.
Vanderbilt University, 9/1/98-8/301/99. $138,300.

33. Principal Investigator, "Integrative Group Treatment for Depression."
NIMH (R21), 6/99-3/03. $298,084.

34. Sponsor, "Predictors of Relapse in Major Depression." Michael Friedman, PI.
NARSAD, 7/1/99-6/30/01. $60,000.

35. Principal Investigator, "Combined Treatment for Depressed Inpatients."
NIMH (RO1), 2/00-1/06. $3,289,792.

36. Co-Principal Investigator, "Treatment of Depression in IV Drug Abusers." Michael Stein, PI.
NIMH (RO1), 9/30/99-8/31/03. $1,169,268.

37. Sponsor, "Preventing Depression Among Minority Parents." Esteban Cardemil, PI.
NIMH (F32), 7/00-6/02. $63,332.

38. Co-Principal Investigator, "Maintaining HIV Risk Reduction Among Needle Exchangers." Michael Stein, PI.
NIMH (RO1), 10/1/00-9/30//05. $1,427,785.

39. Co-Principal Investigator, "Adapting to HIV Disease – A Family Intervention." Michael Stein, PI.
NIMH (RO1), 10/1/00-9/30/05. $1,448,250.

40. Principal Investigator, "Forgiveness in Families."
Campaign for Forgiveness, 9/1/00-8/31/03. $174,164.

41. Co-Principal Investigator, "Treatment of Women with Depression and Sexual Abuse," Caron Zlotnick, PI.
NIMH (R21), 4/1/01-3/30/03. $299,179.

42. Sponsor, "Motivating Couples for Therapy." Lisa Uebelacker, PI.
NIMH (F32), 7/01-6/03. $63,332.

43. Co-Principal Investigator, "Depression Intervention for Poor Pregnant Women," Caron Zlotnick, PI.
NIMH (R21), 9/1/01-8/30/04. $299,179.

44. Investigator, "A Telephone Intervention for Dementia Caregivers." Geoff Tremont, PI.
NIMH (R21), 12/1/01 - 11/30/04. $375,000.

45. Sponsor, "Preventing Depression in Latino Families." Esteban Cardemil, PI.
NIMH (KO1), 7/1/02 - 6/30/07. $700,000.

46. Sponsor, "Developing a Family Treatment for Post-Partum Depression." Cynthia Battle, PI.
NIMH (K23), 7/1/02 - 6/30/07. $700,000.

47. Consultant, "Omega-3 Fatty Acids for Treatment of Postpartum Depression." Marlene Freeman, PI.
NIMH (K23), 7/1/02-6/30/07. $700,000.

48. Investigator, "Improving Smoking Cessation in Smokers with Depressive Symptoms." Richard Brown, PI.
American Cancer Society, 7/1/02-6/30/04.

49. Co-Investigator, "CBASP Augmentation for Treatment of Chronic Depression." Martin Keller, PI.
NIMH (RO1), 9/02-7/06. $1,119,585.

50. Principal Investigator, "Training in Treatment Research."
NIMH (T32), 7/1/03 – 6/30/08. $1,520,373.

51. Sponsor, "Treatments for Psychogenic Non-Epileptic Seizures, " Curt LaFrance, PI.
NINDS (K23), 7/1/03-6/30/08. $700,000.

52. Investigator, "Brief Alcohol Intervention with Depressed Patients." Susan Ramsey, PI.
NIAAA (RO1), 9/3/03 – 8/31/08, $1,200,00

53. Sponsor, "Psychotherapy for Depressed Primary Care Patients." Lisa Uebelacker, PI.
NIMH (K23), 12/1/03-11/30/08. $700,000.

54. Mentor, "Depression and coronary heart disease." John Todaro, PI.
NARSAD, 7/1/04-6/30/06. $60,000.

55. Investigator, "Mood Management Phone Counseling in Smoking Cessation." David Strong, PI.
NIDA, 7/1/04-6/30-07, $750,000.

56. Principal Investigator, "Treatment of Suicide in Alcoholic and Depressed Patients."
NIAAA (RO1), 1/06-12/09. $980,224.